Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

ZM Younossi; V Ratziu; R Loomba; M Rinella; QM Anstee; Z Goodman; P Bedossa; A Geier; S Beckebaum; PN Newsome; D Sheridan; MY Sheikh; J Trotter; REGENERATE Study Investigators

doi:10.1016/s0140-6736(19)33041-7

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, P Bedossa, A Geier, S Beckebaum, PN Newsome, D Sheridan, MY Sheikh, J Trotter, REGENERATE Study Investigators

Research output: Contribution to journal › Article › peer-review

231 Citations (Scopus)

Original language	English
Pages (from-to)	2184-2196
Journal	Lancet (London, England)
Volume	394
DOIs	https://doi.org/10.1016/s0140-6736(19)33041-7
Publication status	Published - Dec 2019

Access to Document

10.1016/s0140-6736(19)33041-7

Cite this

Younossi, ZM., Ratziu, V., Loomba, R., Rinella, M., Anstee, QM., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, PN., Sheridan, D., Sheikh, MY., Trotter, J., & Investigators, REGENERATE. S. (2019). Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet (London, England), 394, 2184-2196. https://doi.org/10.1016/s0140-6736(19)33041-7

@article{91944932df824a36a26c8e1deb6cd23b,

title = "Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.",

author = "ZM Younossi and V Ratziu and R Loomba and M Rinella and QM Anstee and Z Goodman and P Bedossa and A Geier and S Beckebaum and PN Newsome and D Sheridan and MY Sheikh and J Trotter and Investigators, {REGENERATE Study}",

year = "2019",

month = dec,

doi = "10.1016/s0140-6736(19)33041-7",

language = "English",

volume = "394",

pages = "2184--2196",

journal = "Lancet (London, England)",

}

Younossi, ZM, Ratziu, V, Loomba, R, Rinella, M, Anstee, QM, Goodman, Z, Bedossa, P, Geier, A, Beckebaum, S, Newsome, PN, Sheridan, D, Sheikh, MY, Trotter, J & Investigators, REGENERATES 2019, 'Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.', Lancet (London, England), vol. 394, pp. 2184-2196. https://doi.org/10.1016/s0140-6736(19)33041-7

TY - JOUR

T1 - Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

AU - Younossi, ZM

AU - Ratziu, V

AU - Loomba, R

AU - Rinella, M

AU - Anstee, QM

AU - Goodman, Z

AU - Bedossa, P

AU - Geier, A

AU - Beckebaum, S

AU - Newsome, PN

AU - Sheridan, D

AU - Sheikh, MY

AU - Trotter, J

AU - Investigators, REGENERATE Study

PY - 2019/12

Y1 - 2019/12

UR - http://europepmc.org/abstract/med/31813633

U2 - 10.1016/s0140-6736(19)33041-7

DO - 10.1016/s0140-6736(19)33041-7

M3 - Article

C2 - 31813633

VL - 394

SP - 2184

EP - 2196

JO - Lancet (London, England)

JF - Lancet (London, England)

ER -